Table 4.
Size (nm)b | Surface coating | Rodent | Administration | Dosage (mg/kg/day) | Duration (days) | Toxicityc | Reference | |
---|---|---|---|---|---|---|---|---|
53 | Citrate | Male ICR mice Female ICR mice |
Oral | 0.2, 2 and 20 | 90 | – | Current study | |
5 (8.6) 5 (8.7) 5-60 (11.6–89.8) |
Citrate PVP Tannic acid |
Male C57BL/6 mice | Oral | 0.025 0.025 0.015–0.025 |
8 | – | Zhu et al. [33] | |
13.5 | Citrate | Male ICR mice | Oral | 0.1375–2.2 1.1 |
14 28 |
± ± |
Zhang et al. [8] | |
10–25 | Citrate | Male Wistar rats | Oral | 0.02 | 21 | + | Rathore et al. [25] | |
5–15 | Citrate | Female SD rats | Oral | 0.325–1.3 | 14 | – | Jo et al. [34] | |
1–25 | Polyphenold | Male Wistar rats | Oral | 5 and 10 | 28 | - | Mata et al. [35] |
AuNPs are prepared in spherical shape by reduction of AuClO4 in citrate solution unless otherwise specified.
The size of citrate coated AuNPs determined by TEM. The number in parenthesis indicates the size determined by DLS.
Significant toxicity, +; no or insignificant toxicity, –; some or ambiguous toxicity, ±.
AuNPs (spherical shape) were prepared in plant extract of Abutilon Indicum.